Clinical utility and cost assessment of proteinuria monitoring for patients receiving bevacizumab in a gynecology oncology clinic

akin to thrombocytosis? C.C. Gunderson, K.N. Slaughter, E.D. Thomas, R. Farrell, K. Ding, J.K. Lauer, L.J. Perry, D.S. McMeekin, K.N. Moore. University of Oklahoma Health Sciences Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Oklahoma City, OK, USA, The University of Oklahoma Health Sciences Center, College of Public Health, Department of Biostatistics and Epidemiology, Oklahoma City, OK, USA.